Gilead announces higher copay card amount for Truvada, effective January 1, 2018

During a conference call on December 19 with community members, Gilead (the maker of Truvada) announced that beginning January 1, 2018 the co-pay assistance amount for Truvada for PrEP and treatment will increase to $4,800 from the previous limit of $3,600. A formal announcement will likely be made by Gilead soon.